Characterization and clinical use of inflammatory cerebrospinal fluid protein markers in Alzheimer’s disease

BACKGROUND: Neuroinflammation has gained increasing attention as a potential contributing factor in Alzheimer’s disease (AD) pathology. A clinical cerebrospinal fluid biomarker capable of monitoring this process during the course of the disease has yet to emerge, chiefly owing to contradictory resea...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Alzheimers Res Ther
Главные авторы: Brosseron, Frederic, Traschütz, Andreas, Widmann, Catherine N., Kummer, Markus P., Tacik, Pawel, Santarelli, Francesco, Jessen, Frank, Heneka, Michael T.
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2018
Предметы:
Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5828084/
https://ncbi.nlm.nih.gov/pubmed/29482610
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-018-0353-3
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы